There are four effector molecules that are candidates for involvement in the lytic function expressed by CD8+ cytotoxic T lymphocytes (CTLs): perforin, TNF-alpha, TNF-Beta, and IFN-gamma. In order to assess definitively the role of each of these molecules in CTL function, we propose to create cloned CTL lines that lack the perforin gene, and cloned CTL lines that lack the perforin gene plus one of the other three candidate genes (TNF-alpha, TNF-Beta or IFN-gamma). We propose to do this by the process of targeted gene disruption via homologous recombination. We will use the same process with ES cells to generate an inbred strain of mice completely lacking perforin genes. Such mice will also be a source for generation of perforin-less (P0) CTL clones. In preliminary work, we have produced mosaic mice from ES cells with one perforin allele disrupted. These mice are now being mated to produce a perforin-less mouse strain. This work will have the following principal aims: 1. Short range: (a) Generate cloned CTL lines with both copies of the perforin gene disrupted. This will provide a definitive answer to the question of whether perforin per se is required for classically defined CTL killing in vitro. (b) Generate additional ES cells with one perforin allele disrupted. 2. Intermediate range: (a) Use the perforin-less (P0) cloned CTL lines for the study of alternate pathways of CTL killing in the unambiguous absence of perforin as a lytic mechanism. P0 CTL lines will be used as starting material for the systematic elimination of TNF-alpha, TNF-Beta and IFN-gamma genes. (b) Produce inbred mice with both perforin alleles disrupted. 3. Long range: Use the inbred lines of mice homozygous-defective for the perforin gene to analyze the role of perforin in three CD8+T cell functions in vivo: graft rejection, viral clearance and tumor control.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI032512-01A1
Application #
3147629
Study Section
Experimental Immunology Study Section (EI)
Project Start
1993-04-01
Project End
1996-03-31
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Arts and Sciences
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Jensen, E R; Glass, A A; Clark, W R et al. (1998) Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes. Infect Immun 66:4143-50
Glass, A; Walsh, C M; Lynch, D H et al. (1996) Regulation of the Fas lytic pathway in cloned CTL. J Immunol 156:3638-44
Walsh, C M; Hayashi, F; Saffran, D C et al. (1996) Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection. J Immunol 156:1436-41
Liu, C C; Walsh, C M; Eto, N et al. (1995) Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells. J Immunol 155:602-8
Clark, W R; Walsh, C M; Glass, A A et al. (1995) Cell-mediated cytotoxicity in perforin-less mice. Int Rev Immunol 13:1-14
Chiu, V K; Walsh, C M; Liu, C C et al. (1995) Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity. J Immunol 154:2023-32
Walsh, C M; Matloubian, M; Liu, C C et al. (1994) Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A 91:10854-8
Walsh, C M; Glass, A A; Chiu, V et al. (1994) The role of the Fas lytic pathway in a perforin-less CTL hybridoma. J Immunol 153:2506-14
Silvestre, A J; Zhou, S Y; Kingsley, L A et al. (1993) Secondary prevention of HIV: knowledge and beliefs about HIV, therapy and community resources. AIDS 7:899-900
Davidson, M; Letson, G W; Ward, J I et al. (1991) DTP immunization and susceptibility to infectious diseases. Is there a relationship? Am J Dis Child 145:750-4

Showing the most recent 10 out of 14 publications